Drug Development

Blog Post

Clinical Trial Alert: Biogen Seeks Participants for a Phase 3 SOD1-ALS Study

By MDA Staff | May 30, 2019
Blog Post

Clinical Trial Alert: Alexion Pharmaceuticals Seeks Participants for a Phase 3 Pediatric Myasthenia Gravis Study

By MDA Staff | May 30, 2019
Blog Post

Do You Know ALS? Meet Dr. Cudkowicz.

By MDA Staff | May 27, 2019
Blog Post

Do You Know ALS? Meet Tim.

By MDA Staff | May 26, 2019
Blog Post

Do You Know ALS? Read About the Latest Research.

By Jeanene Swanson | May 15, 2019
Blog Post

Biogen Releases Letter to ALS Community

By MDA Staff | May 2, 2019
Blog Post

Clinical Trial Alert: PTC Therapeutics Seeks Participants for a Phase 3 DMD Study

By MDA Staff | April 24, 2019
Blog Post

Audentes Therapeutics Announces Plans to Develop Gene-Targeted Therapies for Duchenne Muscular Dystrophy and Myotonic Dystrophy Type 1

By Jeanene Swanson | April 11, 2019
Blog Post

Muscular Dystrophy Association Awards Eight Grants Totaling More Than $2 Million for ALS Research

By Jeanene Swanson | April 8, 2019
Blog Post

Sarepta Therapeutics Announces Positive Interim Results from Study of Casimersen to Treat DMD Amenable to Exon 45 Skipping

By Jeanene Swanson | April 4, 2019